deep neuromuscular block
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postoperative Complications
Conditions
Postoperative Complications, Postoperative Wound Infection, Pneumonia
Trial Timeline
Jun 1, 2017 → Jul 1, 2018
NCT ID
NCT03174223About deep neuromuscular block
deep neuromuscular block is a pre-clinical stage product being developed by Merck for Postoperative Complications. The current trial status is completed. This product is registered under clinical trial identifier NCT03174223. Target conditions include Postoperative Complications, Postoperative Wound Infection, Pneumonia.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03170661 | Approved | Completed |
| NCT03174223 | Pre-clinical | Completed |
Competing Products
20 competing products in Postoperative Complications